Global Cancer Treatment Drugs Market Growth 2022-2028
As the global economy mends, the 2021 growth of Cancer Treatment Drugs will have significant change from previous year. According to our latest study, the global Cancer Treatment Drugs market size is USD million in 2022 from USD 174990 million in 2021, with a change of % between 2021 and 2022. The global Cancer Treatment Drugs market size will reach USD 322540 million in 2028, growing at a CAGR of 9.1% over the analysis period.
The United States Cancer Treatment Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cancer Treatment Drugs market, reaching US$ million by the year 2028. As for the Europe Cancer Treatment Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cancer Treatment Drugs players cover Roche, Novartis, Celgene, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Treatment Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cancer Treatment Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cancer Treatment Drugs by Country/Region, 2017, 2022 & 2028
2.2 Cancer Treatment Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy (Biologic Therapy)
2.2.5 Others
2.3 Cancer Treatment Drugs Sales by Type
2.3.1 Global Cancer Treatment Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cancer Treatment Drugs Sale Price by Type (2017-2022)
2.4 Cancer Treatment Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory or Lung Cancer
2.4.6 Others
2.5 Cancer Treatment Drugs Sales by Application
2.5.1 Global Cancer Treatment Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Cancer Treatment Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cancer Treatment Drugs Sale Price by Application (2017-2022)
3 Global Cancer Treatment Drugs by Company
3.1 Global Cancer Treatment Drugs Breakdown Data by Company
3.1.1 Global Cancer Treatment Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Cancer Treatment Drugs Sales Market Share by Company (2020-2022)
3.2 Global Cancer Treatment Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Cancer Treatment Drugs Revenue by Company (2020-2022)
3.2.2 Global Cancer Treatment Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Cancer Treatment Drugs Sale Price by Company
3.4 Key Manufacturers Cancer Treatment Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cancer Treatment Drugs Product Location Distribution
3.4.2 Players Cancer Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cancer Treatment Drugs by Geographic Region
4.1 World Historic Cancer Treatment Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Cancer Treatment Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cancer Treatment Drugs Annual Revenue by Geographic Region
4.2 World Historic Cancer Treatment Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Cancer Treatment Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cancer Treatment Drugs Annual Revenue by Country/Region
4.3 Americas Cancer Treatment Drugs Sales Growth
4.4 APAC Cancer Treatment Drugs Sales Growth
4.5 Europe Cancer Treatment Drugs Sales Growth
4.6 Middle East & Africa Cancer Treatment Drugs Sales Growth
5 Americas
5.1 Americas Cancer Treatment Drugs Sales by Country
5.1.1 Americas Cancer Treatment Drugs Sales by Country (2017-2022)
5.1.2 Americas Cancer Treatment Drugs Revenue by Country (2017-2022)
5.2 Americas Cancer Treatment Drugs Sales by Type
5.3 Americas Cancer Treatment Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Treatment Drugs Sales by Region
6.1.1 APAC Cancer Treatment Drugs Sales by Region (2017-2022)
6.1.2 APAC Cancer Treatment Drugs Revenue by Region (2017-2022)
6.2 APAC Cancer Treatment Drugs Sales by Type
6.3 APAC Cancer Treatment Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cancer Treatment Drugs by Country
7.1.1 Europe Cancer Treatment Drugs Sales by Country (2017-2022)
7.1.2 Europe Cancer Treatment Drugs Revenue by Country (2017-2022)
7.2 Europe Cancer Treatment Drugs Sales by Type
7.3 Europe Cancer Treatment Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cancer Treatment Drugs by Country
8.1.1 Middle East & Africa Cancer Treatment Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cancer Treatment Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Cancer Treatment Drugs Sales by Type
8.3 Middle East & Africa Cancer Treatment Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cancer Treatment Drugs
10.3 Manufacturing Process Analysis of Cancer Treatment Drugs
10.4 Industry Chain Structure of Cancer Treatment Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cancer Treatment Drugs Distributors
11.3 Cancer Treatment Drugs Customer
12 World Forecast Review for Cancer Treatment Drugs by Geographic Region
12.1 Global Cancer Treatment Drugs Market Size Forecast by Region
12.1.1 Global Cancer Treatment Drugs Forecast by Region (2023-2028)
12.1.2 Global Cancer Treatment Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cancer Treatment Drugs Forecast by Type
12.7 Global Cancer Treatment Drugs Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Cancer Treatment Drugs Product Offered
13.1.3 Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Cancer Treatment Drugs Product Offered
13.2.3 Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Celgene
13.3.1 Celgene Company Information
13.3.2 Celgene Cancer Treatment Drugs Product Offered
13.3.3 Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Celgene Main Business Overview
13.3.5 Celgene Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Cancer Treatment Drugs Product Offered
13.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Cancer Treatment Drugs Product Offered
13.5.3 Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Cancer Treatment Drugs Product Offered
13.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Cancer Treatment Drugs Product Offered
13.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda Cancer Treatment Drugs Product Offered
13.8.3 Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Cancer Treatment Drugs Product Offered
13.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 AstraZeneca
13.10.1 AstraZeneca Company Information
13.10.2 AstraZeneca Cancer Treatment Drugs Product Offered
13.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 AstraZeneca Main Business Overview
13.10.5 AstraZeneca Latest Developments
13.11 Astellas
13.11.1 Astellas Company Information
13.11.2 Astellas Cancer Treatment Drugs Product Offered
13.11.3 Astellas Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Astellas Main Business Overview
13.11.5 Astellas Latest Developments
13.12 Merck & Co.
13.12.1 Merck & Co. Company Information
13.12.2 Merck & Co. Cancer Treatment Drugs Product Offered
13.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Merck & Co. Main Business Overview
13.12.5 Merck & Co. Latest Developments
13.13 Sanofi
13.13.1 Sanofi Company Information
13.13.2 Sanofi Cancer Treatment Drugs Product Offered
13.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Sanofi Main Business Overview
13.13.5 Sanofi Latest Developments
13.14 Bayer
13.14.1 Bayer Company Information
13.14.2 Bayer Cancer Treatment Drugs Product Offered
13.14.3 Bayer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Bayer Main Business Overview
13.14.5 Bayer Latest Developments
13.15 Biogen Idec
13.15.1 Biogen Idec Company Information
13.15.2 Biogen Idec Cancer Treatment Drugs Product Offered
13.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Biogen Idec Main Business Overview
13.15.5 Biogen Idec Latest Developments
13.16 Eisai
13.16.1 Eisai Company Information
13.16.2 Eisai Cancer Treatment Drugs Product Offered
13.16.3 Eisai Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Eisai Main Business Overview
13.16.5 Eisai Latest Developments
13.17 Teva
13.17.1 Teva Company Information
13.17.2 Teva Cancer Treatment Drugs Product Offered
13.17.3 Teva Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Teva Main Business Overview
13.17.5 Teva Latest Developments
13.18 Otsuka
13.18.1 Otsuka Company Information
13.18.2 Otsuka Cancer Treatment Drugs Product Offered
13.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Otsuka Main Business Overview
13.18.5 Otsuka Latest Developments
13.19 Merck KGaA
13.19.1 Merck KGaA Company Information
13.19.2 Merck KGaA Cancer Treatment Drugs Product Offered
13.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Merck KGaA Main Business Overview
13.19.5 Merck KGaA Latest Developments
13.20 Ipsen
13.20.1 Ipsen Company Information
13.20.2 Ipsen Cancer Treatment Drugs Product Offered
13.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Ipsen Main Business Overview
13.20.5 Ipsen Latest Developments
13.21 AbbVie
13.21.1 AbbVie Company Information
13.21.2 AbbVie Cancer Treatment Drugs Product Offered
13.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 AbbVie Main Business Overview
13.21.5 AbbVie Latest Developments
13.22 Gilead Sciences
13.22.1 Gilead Sciences Company Information
13.22.2 Gilead Sciences Cancer Treatment Drugs Product Offered
13.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Gilead Sciences Main Business Overview
13.22.5 Gilead Sciences Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Cancer Treatment Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cancer Treatment Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Hormonal Therapy (Biologic Therapy)
Table 7. Major Players of Others
Table 8. Global Cancer Treatment Drugs Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Cancer Treatment Drugs Sales Market Share by Type (2017-2022)
Table 10. Global Cancer Treatment Drugs Revenue by Type (2017-2022) & ($ million)
Table 11. Global Cancer Treatment Drugs Revenue Market Share by Type (2017-2022)
Table 12. Global Cancer Treatment Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Cancer Treatment Drugs Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Cancer Treatment Drugs Sales Market Share by Application (2017-2022)
Table 15. Global Cancer Treatment Drugs Revenue by Application (2017-2022)
Table 16. Global Cancer Treatment Drugs Revenue Market Share by Application (2017-2022)
Table 17. Global Cancer Treatment Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Cancer Treatment Drugs Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Cancer Treatment Drugs Sales Market Share by Company (2020-2022)
Table 20. Global Cancer Treatment Drugs Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Cancer Treatment Drugs Revenue Market Share by Company (2020-2022)
Table 22. Global Cancer Treatment Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Cancer Treatment Drugs Producing Area Distribution and Sales Area
Table 24. Players Cancer Treatment Drugs Products Offered
Table 25. Cancer Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Cancer Treatment Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Cancer Treatment Drugs Sales Market Share Geographic Region (2017-2022)
Table 30. Global Cancer Treatment Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Cancer Treatment Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Cancer Treatment Drugs Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Cancer Treatment Drugs Sales Market Share by Country/Region (2017-2022)
Table 34. Global Cancer Treatment Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Cancer Treatment Drugs Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Cancer Treatment Drugs Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Cancer Treatment Drugs Sales Market Share by Country (2017-2022)
Table 38. Americas Cancer Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Cancer Treatment Drugs Revenue Market Share by Country (2017-2022)
Table 40. Americas Cancer Treatment Drugs Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Cancer Treatment Drugs Sales Market Share by Type (2017-2022)
Table 42. Americas Cancer Treatment Drugs Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Cancer Treatment Drugs Sales Market Share by Application (2017-2022)
Table 44. APAC Cancer Treatment Drugs Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Cancer Treatment Drugs Sales Market Share by Region (2017-2022)
Table 46. APAC Cancer Treatment Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Cancer Treatment Drugs Revenue Market Share by Region (2017-2022)
Table 48. APAC Cancer Treatment Drugs Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Cancer Treatment Drugs Sales Market Share by Type (2017-2022)
Table 50. APAC Cancer Treatment Drugs Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Cancer Treatment Drugs Sales Market Share by Application (2017-2022)
Table 52. Europe Cancer Treatment Drugs Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Cancer Treatment Drugs Sales Market Share by Country (2017-2022)
Table 54. Europe Cancer Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Cancer Treatment Drugs Revenue Market Share by Country (2017-2022)
Table 56. Europe Cancer Treatment Drugs Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Cancer Treatment Drugs Sales Market Share by Type (2017-2022)
Table 58. Europe Cancer Treatment Drugs Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Cancer Treatment Drugs Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Cancer Treatment Drugs Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Cancer Treatment Drugs Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Cancer Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Cancer Treatment Drugs Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Cancer Treatment Drugs Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Cancer Treatment Drugs Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Cancer Treatment Drugs Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Cancer Treatment Drugs Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Cancer Treatment Drugs
Table 69. Key Market Challenges & Risks of Cancer Treatment Drugs
Table 70. Key Industry Trends of Cancer Treatment Drugs
Table 71. Cancer Treatment Drugs Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Cancer Treatment Drugs Distributors List
Table 74. Cancer Treatment Drugs Customer List
Table 75. Global Cancer Treatment Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Cancer Treatment Drugs Sales Market Forecast by Region
Table 77. Global Cancer Treatment Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Cancer Treatment Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Cancer Treatment Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Cancer Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Cancer Treatment Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Cancer Treatment Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Cancer Treatment Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Cancer Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Cancer Treatment Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Cancer Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Cancer Treatment Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Cancer Treatment Drugs Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Cancer Treatment Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Cancer Treatment Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Cancer Treatment Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Cancer Treatment Drugs Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Cancer Treatment Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Cancer Treatment Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 95. Roche Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Cancer Treatment Drugs Product Offered
Table 97. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Roche Main Business
Table 99. Roche Latest Developments
Table 100. Novartis Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis Cancer Treatment Drugs Product Offered
Table 102. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Novartis Main Business
Table 104. Novartis Latest Developments
Table 105. Celgene Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Celgene Cancer Treatment Drugs Product Offered
Table 107. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Celgene Main Business
Table 109. Celgene Latest Developments
Table 110. Bristol-Myers Squibb Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Bristol-Myers Squibb Cancer Treatment Drugs Product Offered
Table 112. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Bristol-Myers Squibb Main Business
Table 114. Bristol-Myers Squibb Latest Developments
Table 115. Amgen Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Amgen Cancer Treatment Drugs Product Offered
Table 117. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Amgen Main Business
Table 119. Amgen Latest Developments
Table 120. Johnson & Johnson Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Johnson & Johnson Cancer Treatment Drugs Product Offered
Table 122. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Johnson & Johnson Main Business
Table 124. Johnson & Johnson Latest Developments
Table 125. Pfizer Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer Cancer Treatment Drugs Product Offered
Table 127. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Pfizer Main Business
Table 129. Pfizer Latest Developments
Table 130. Takeda Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Cancer Treatment Drugs Product Offered
Table 132. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Takeda Main Business
Table 134. Takeda Latest Developments
Table 135. Eli Lilly Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Eli Lilly Cancer Treatment Drugs Product Offered
Table 137. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Eli Lilly Main Business
Table 139. Eli Lilly Latest Developments
Table 140. AstraZeneca Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. AstraZeneca Cancer Treatment Drugs Product Offered
Table 142. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. AstraZeneca Main Business
Table 144. AstraZeneca Latest Developments
Table 145. Astellas Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Astellas Cancer Treatment Drugs Product Offered
Table 147. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Astellas Main Business
Table 149. Astellas Latest Developments
Table 150. Merck & Co. Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Merck & Co. Cancer Treatment Drugs Product Offered
Table 152. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Merck & Co. Main Business
Table 154. Merck & Co. Latest Developments
Table 155. Sanofi Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Sanofi Cancer Treatment Drugs Product Offered
Table 157. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 158. Sanofi Main Business
Table 159. Sanofi Latest Developments
Table 160. Bayer Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Bayer Cancer Treatment Drugs Product Offered
Table 162. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 163. Bayer Main Business
Table 164. Bayer Latest Developments
Table 165. Biogen Idec Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Biogen Idec Cancer Treatment Drugs Product Offered
Table 167. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 168. Biogen Idec Main Business
Table 169. Biogen Idec Latest Developments
Table 170. Eisai Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 171. Eisai Cancer Treatment Drugs Product Offered
Table 172. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 173. Eisai Main Business
Table 174. Eisai Latest Developments
Table 175. Teva Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 176. Teva Cancer Treatment Drugs Product Offered
Table 177. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 178. Teva Main Business
Table 179. Teva Latest Developments
Table 180. Otsuka Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 181. Otsuka Cancer Treatment Drugs Product Offered
Table 182. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 183. Otsuka Main Business
Table 184. Otsuka Latest Developments
Table 185. Merck KGaA Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 186. Merck KGaA Cancer Treatment Drugs Product Offered
Table 187. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 188. Merck KGaA Main Business
Table 189. Merck KGaA Latest Developments
Table 190. Ipsen Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 191. Ipsen Cancer Treatment Drugs Product Offered
Table 192. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 193. Ipsen Main Business
Table 194. Ipsen Latest Developments
Table 195. AbbVie Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 196. AbbVie Cancer Treatment Drugs Product Offered
Table 197. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 198. AbbVie Main Business
Table 199. AbbVie Latest Developments
Table 200. Gilead Sciences Basic Information, Cancer Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 201. Gilead Sciences Cancer Treatment Drugs Product Offered
Table 202. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 203. Gilead Sciences Main Business
Table 204. Gilead Sciences Latest Developments
List of Figures
Figure 1. Picture of Cancer Treatment Drugs
Figure 2. Cancer Treatment Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cancer Treatment Drugs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Cancer Treatment Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cancer Treatment Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Chemotherapy
Figure 10. Product Picture of Targeted Therapy
Figure 11. Product Picture of Immunotherapy
Figure 12. Product Picture of Hormonal Therapy (Biologic Therapy)
Figure 13. Product Picture of Others
Figure 14. Global Cancer Treatment Drugs Sales Market Share by Type in 2021
Figure 15. Global Cancer Treatment Drugs Revenue Market Share by Type (2017-2022)
Figure 16. Cancer Treatment Drugs Consumed in Blood Cancer
Figure 17. Global Cancer Treatment Drugs Market: Blood Cancer (2017-2022) & (K Pcs)
Figure 18. Cancer Treatment Drugs Consumed in Breast Cancer
Figure 19. Global Cancer Treatment Drugs Market: Breast Cancer (2017-2022) & (K Pcs)
Figure 20. Cancer Treatment Drugs Consumed in Gastrointestinal Cancer
Figure 21. Global Cancer Treatment Drugs Market: Gastrointestinal Cancer (2017-2022) & (K Pcs)
Figure 22. Cancer Treatment Drugs Consumed in Prostate Cancer
Figure 23. Global Cancer Treatment Drugs Market: Prostate Cancer (2017-2022) & (K Pcs)
Figure 24. Cancer Treatment Drugs Consumed in Respiratory or Lung Cancer
Figure 25. Global Cancer Treatment Drugs Market: Respiratory or Lung Cancer (2017-2022) & (K Pcs)
Figure 26. Cancer Treatment Drugs Consumed in Others
Figure 27. Global Cancer Treatment Drugs Market: Others (2017-2022) & (K Pcs)
Figure 28. Global Cancer Treatment Drugs Sales Market Share by Application (2017-2022)
Figure 29. Global Cancer Treatment Drugs Revenue Market Share by Application in 2021
Figure 30. Cancer Treatment Drugs Revenue Market by Company in 2021 ($ Million)
Figure 31. Global Cancer Treatment Drugs Revenue Market Share by Company in 2021
Figure 32. Global Cancer Treatment Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 33. Global Cancer Treatment Drugs Revenue Market Share by Geographic Region in 2021
Figure 34. Global Cancer Treatment Drugs Sales Market Share by Region (2017-2022)
Figure 35. Global Cancer Treatment Drugs Revenue Market Share by Country/Region in 2021
Figure 36. Americas Cancer Treatment Drugs Sales 2017-2022 (K Pcs)
Figure 37. Americas Cancer Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 38. APAC Cancer Treatment Drugs Sales 2017-2022 (K Pcs)
Figure 39. APAC Cancer Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 40. Europe Cancer Treatment Drugs Sales 2017-2022 (K Pcs)
Figure 41. Europe Cancer Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 42. Middle East & Africa Cancer Treatment Drugs Sales 2017-2022 (K Pcs)
Figure 43. Middle East & Africa Cancer Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 44. Americas Cancer Treatment Drugs Sales Market Share by Country in 2021
Figure 45. Americas Cancer Treatment Drugs Revenue Market Share by Country in 2021
Figure 46. United States Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Canada Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Mexico Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Brazil Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. APAC Cancer Treatment Drugs Sales Market Share by Region in 2021
Figure 51. APAC Cancer Treatment Drugs Revenue Market Share by Regions in 2021
Figure 52. China Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Japan Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. South Korea Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Southeast Asia Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. India Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Australia Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Europe Cancer Treatment Drugs Sales Market Share by Country in 2021
Figure 59. Europe Cancer Treatment Drugs Revenue Market Share by Country in 2021
Figure 60. Germany Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. France Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. UK Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Italy Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Russia Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Middle East & Africa Cancer Treatment Drugs Sales Market Share by Country in 2021
Figure 66. Middle East & Africa Cancer Treatment Drugs Revenue Market Share by Country in 2021
Figure 67. Egypt Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 68. South Africa Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. Israel Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. Turkey Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 71. GCC Country Cancer Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Cancer Treatment Drugs in 2021
Figure 73. Manufacturing Process Analysis of Cancer Treatment Drugs
Figure 74. Industry Chain Structure of Cancer Treatment Drugs
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
